Sort
48,018 grants matching “immunotherapy”
First-in-human study of a potent anti-HBsAg neutralizing antibody
$864,658Marina Caskey · Rockefeller University · U01 · FY2023 · AI
Integrated Multi-omics of Melioidosis
$864,642Timothy Eoin West · University Of Washington · R01 · FY2020 · AI
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases
$864,620James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZID · FY2012 · DK
Preclinical Development of a Novel and Powerful Immunotherapeutic
$864,478Susan Dana Jones · Immurx Llc · R44 · FY2013 · AI
Innovation of Biobanking for Cellular Adoptive Immunotherapies Based on a First-in-Class Biocompatible Cryopreservation Technology for T and NK Cells and Their CAR-Engineered Products
$864,173Xu Han · Cryocrate, Llc · R44 · FY2023 · CA
Programming T Cell Fates for Therapeutic Use
$864,150Luca Gattinoni · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
COVID-19 vaccine development
$863,806George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy
$863,755Jyothi Rengarajan · Emory University · R01 · FY2024 · AI
Clinical trials employing cancer vaccine combination therapies
$863,733James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$863,733James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
NIH Chronic GVHD Study Group
$863,692Steven Pavletic · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$863,617Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Biostatistics Shared Resources Core
$863,560Motomi Mori · St. Jude Children'S Research Hospital · P30 · FY2020 · CA
Biostatistics Shared Resources Core
$863,560Motomi Mori · St. Jude Children'S Research Hospital · P30 · FY2023 · CA
Biostatistics Shared Resources Core
$863,560Motomi Mori · St. Jude Children'S Research Hospital · P30 · FY2022 · CA
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
$863,419Ronald Levy · Stanford University · R35 · FY2020 · CA
Antibody Based Therapeuticcs for Chikungunya Virus
$863,223Michael S. Diamond · Washington University · R01 · FY2011 · AI
Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoea
$862,755Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$862,729Damian J. Green · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques
$862,669Donald L Sodora · Seattle Children'S Hospital · R01 · FY2024 · AI
Southern Nevada Cancer Research Foundation--CCOP
$862,500Southern Nevada Cancer Research Fdn · U10 · FY2005 · CA
Immune Mechanisms, Genetic and Environmental Factors Influencing Outcomes
$862,445Scott H Sicherer · Icahn School Of Medicine At Mount Sinai · U19 · FY2010 · AI
A new humanized mouse model to study HBV gene editing
$862,440Keith R Jerome · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
Enhancing Susceptibility of HIV Reservoirs to CTL Through a Discovery to Translational Approach
$862,207R. Brad Jones · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$861,992Damian J. Green · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA